Is Tyco After Bard?

Shares of Big Board-listed C.R. Bard (BCR) were flying high in the spring, when rumors swirled that Baxter International was in pursuit of Bard, which makes a wide range of disposable therapeutic and diagnostic devices used by hospitals, doctors, and nursing homes. The stock had climbed to nearly 60. It has since dropped as the takeover rumors fizzled. That wasn't the first time that Bard's name was bandied about as a target. Last year, there was scuttlebutt that it would be acquired by the hungry Tyco International, a conglomerate whose four core operations include medical supplies. Bard's shares, now at 52, have been edging up of late, from 45 in late September. The reason: Tyco talk is back.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.